142 related articles for article (PubMed ID: 19701787)
1. Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis.
Nagy N; Melchior-Becker A; Fischer JW
Basic Res Cardiol; 2010 Jan; 105(1):29-38. PubMed ID: 19701787
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Takaya T; Kawashima S; Shinohara M; Yamashita T; Toh R; Sasaki N; Inoue N; Hirata K; Yokoyama M
Atherosclerosis; 2006 Jun; 186(2):402-10. PubMed ID: 16157344
[TBL] [Abstract][Full Text] [Related]
4. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice.
Blessing E; Preusch M; Kranzhöfer R; Kinscherf R; Marx N; Rosenfeld ME; Isermann B; Weber CM; Kreuzer J; Gräfe J; Katus HA; Bea F
Atherosclerosis; 2008 Aug; 199(2):295-303. PubMed ID: 18093593
[TBL] [Abstract][Full Text] [Related]
5. Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?
Marzoll A; Melchior-Becker A; Cipollone F; Fischer JW
J Cell Mol Med; 2011 Feb; 15(2):232-43. PubMed ID: 20015203
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.
Iwai M; Inaba S; Tomono Y; Kanno H; Iwanami J; Mogi M; Horiuchi M
Hypertens Res; 2008 Jan; 31(1):161-8. PubMed ID: 18360031
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Kaschina E; Schrader F; Sommerfeld M; Kemnitz UR; Grzesiak A; Krikov M; Unger T
J Hypertens; 2008 Dec; 26(12):2361-73. PubMed ID: 19008714
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis.
Schlimmer N; Kratz M; Böhm M; Baumhäkel M
Br J Pharmacol; 2011 Jun; 163(4):804-14. PubMed ID: 21323898
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages.
Matsumura T; Kinoshita H; Ishii N; Fukuda K; Motoshima H; Senokuchi T; Taketa K; Kawasaki S; Nishimaki-Mogami T; Kawada T; Nishikawa T; Araki E
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1268-75. PubMed ID: 21474824
[TBL] [Abstract][Full Text] [Related]
11. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.
Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B
Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.
Grothusen C; Bley S; Selle T; Luchtefeld M; Grote K; Tietge UJ; Drexler H; Schieffer B
Atherosclerosis; 2005 Sep; 182(1):57-69. PubMed ID: 16115475
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
[TBL] [Abstract][Full Text] [Related]
15. Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm.
Matsumoto S; Kamide K; Banno F; Inoue N; Mochizuki N; Kawano Y; Miyata T
Hypertens Res; 2010 Dec; 33(12):1244-9. PubMed ID: 20882024
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.
Sugiyama H; Kobayashi M; Wang DH; Sunami R; Maeshima Y; Yamasaki Y; Masuoka N; Kira S; Makino H
Nephrol Dial Transplant; 2005 Dec; 20(12):2670-80. PubMed ID: 16141465
[TBL] [Abstract][Full Text] [Related]
18. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
[TBL] [Abstract][Full Text] [Related]
19. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
Kasahara Y; Taguchi A; Uno H; Nakano A; Nakagomi T; Hirose H; Stern DM; Matsuyama T
Brain Res; 2010 Jun; 1340():70-80. PubMed ID: 20388500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]